We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Algorithm Analyzes MRI Scans to Determine Best Rectal Cancer Treatment Strategy

By MedImaging International staff writers
Posted on 27 Sep 2024
Print article
Image: The AI algorithm analyzes MRI scans to better understand how rectal tumors respond to treatment (Photo courtesy of 123RF)
Image: The AI algorithm analyzes MRI scans to better understand how rectal tumors respond to treatment (Photo courtesy of 123RF)

Rectal cancer patients typically follow a standardized treatment protocol that often requires surgery, which carries risks and potential complications, including a reduced quality of life. There is a pressing need for improved markers to evaluate the risk of metastasis and invasion, allowing for personalized therapy recommendations that maximize survival chances. Researchers are now developing an artificial intelligence (AI) algorithm to analyze magnetic resonance imaging (MRI) scans and provide better insights into how rectal tumors respond to treatment.

The AI tool, known as the computational image Rectal Response Classifier (ciRRC), is being developed by researchers at Case Western Reserve University (Cleveland, OH, USA) to enhance the analysis of MRI data beyond the capabilities of human evaluation. Once fully developed and validated, the tool is expected to enable doctors to offer tailored precision oncology treatments. With advancements in treatment options, such as newer combinations of chemotherapy and radiation therapy, ciRRC could help identify patients who may be resistant to certain regimens. This would allow doctors to suggest alternative treatment options, helping patients avoid unnecessary complications and make informed decisions about their treatment level. The researchers also plan to conduct a multi-institutional validation of ciRRC to broaden its potential clinical impact.

Related Links:
Case Western Reserve University

NMUS & MSK Ultrasound
InVisus Pro
New
MRI System
Ingenia Prodiva 1.5T CS
New
Portable HF X-Ray Machine
PORTX
Wall Fixtures
MRI SERIES

Print article

Channels

Ultrasound

view channel
Image: Experimental design of the study (Photo courtesy of Tatiana Estifeeva et al./Biomaterials Advances)

New Contrast Agent for Ultrasound Imaging Ensures Affordable and Safer Medical Diagnostics

Ultrasound imaging is an affordable and non-invasive diagnostic method that uses widely available equipment. However, its results are often not highly accurate, and the image quality is heavily dependent... Read more

Nuclear Medicine

view channel
Image: CD45-PET is a robust, non-invasive tool for imaging inflammation (Photo courtesy of 123RF)

Breakthrough Method Detects Inflammation in Body Using PET Imaging

Inflammation is an immune response that helps protect the body against disease. However, when inflammation becomes chronic and excessive, it can lead to various long-term conditions, including cardiovascular... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.